The role of pharmacogenetics in antidepressants and anxiolytic therapy
Description
Pharmacogenetics can potentially optimize the treatment of neuropsychiatric disorders via the prediction of clinical outcomes of antidepressant and anxiolytic drug administration based on patients’ genetic variations affecting metabolizing cytochrome CYP450 and UGT enzymes, P-glycoprotein ABC transporter, as well as monoamine and GABA metabolic enzymes, transporters, and receptors. Some of these gene candidates, as well as many others, may be epigenetically altered by stress.
Acknowledgements
References
saini neha .,et al(2024)
Get started with this template for freeDon’t start from scratch.
Create professional scientific illustrations quickly and easily, even without any design expertise
- Get started with a huge library of editable icons and templates such as common biological pathways, anatomy, or genetics.
- Create figures that effectively communicate your research in half the time using our editable icons.
- Use our PDB tool to quickly generate and customize protein structures
.gif)
